Abbott Laboratories vs. Nature's Sunshine Products Inc.
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| ABT | NATR | |
|---|---|---|
| Market Cap | $192.51 billion | $272.91 million |
| Revenue (TTM) | $46.59 billion | $492.02 million |
| Net Income (TTM) | $5.42 billion | $18.70 million |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | NATR | |
|---|---|---|
| P/E Ratio | 36.00 | 14.97 |
| Price / Book | 3.72 | 1.61 |
| Price / Sales | 4.13 | 0.55 |
NATR leads on 3 of 3 valuation factors.
Profitability
| ABT | NATR | |
|---|---|---|
| Net Margin | 11.65% | 3.80% |
| Return on Equity | 10.48% | 11.05% |
ABT and NATR split the profitability factors evenly.
Dividend
| ABT | NATR | |
|---|---|---|
| Dividend Yield | 2.27% | — |
| Payout Ratio | 81.55 | — |
ABT and NATR split the dividend factors evenly.
Risk & Sentiment
| ABT | NATR | |
|---|---|---|
| Short Interest | 0.57% | 1.46% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, NATR overview, NATR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.